Booth Mark D

CIK 00014708851 companyLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001470885

Recent Transactions

41 trades

Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2015-02-26$1.66/sh+50,000→ 53,810 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2015-02-26−50,000→ 563,924 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2015-02-26$5.68/sh−50,000→ 3,810 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2015-02-03+88,925→ 88,925 total
Award
Orexigen Therapeutics, Inc.
Common Stock
2014-05-30$5.25/sh+4,218→ 8,028 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2014-02-07+205,000→ 205,000 total
Award
Orexigen Therapeutics, Inc.
Common Stock
2013-11-29$5.34/sh+3,810→ 3,810 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-07-26$7.75/sh−29,045→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2013-07-26$1.66/sh+64,767→ 64,767 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-07-26$7.50/sh−20,000→ 29,045 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2013-07-26−64,767→ 613,924 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-07-26$7.25/sh−15,722→ 49,045 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2013-03-11$1.66/sh+27,685→ 27,685 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2013-03-11−27,685→ 678,691 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-03-11$6.67/sh−27,685→ 0 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2013-02-15+190,000→ 190,000 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2013-01-15$1.66/sh+22,315→ 22,315 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-01-15$6.67/sh−22,215→ 100 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2013-01-15$6.67/sh−100→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2013-01-15−22,315→ 706,376 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Common Stock
2012-06-28$1.66/sh+103,309→ 103,309 total
Sale
Orexigen Therapeutics, Inc.
Common Stock
2012-06-28$5.66/sh−103,309→ 0 total
Exercise/Conversion
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2012-06-28−103,309→ 728,691 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2012-02-27+70,000→ 70,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2012-01-25+280,000→ 280,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-25−832,000→ 832,000 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−150,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−107,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−80,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−45,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-07-22−450,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Employee Stock Option Grant (right to buy)
2011-03-02−107,000→ 0 total
Disposition to Issuer
Orexigen Therapeutics, Inc.
Employee Stock Option Grant (right to buy)
2011-03-02−45,000→ 0 total
Award
Orexigen Therapeutics, Inc.
Employee Stock Option Grant (right to buy)
2011-03-02+45,000→ 45,000 total
Award
Orexigen Therapeutics, Inc.
Employee Stock Option Grant (right to buy)
2011-03-02+107,000→ 107,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2011-01-18+107,000→ 107,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2010-09-20+45,000→ 45,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2010-09-01+75,000→ 75,000 total
Award
Orexigen Therapeutics, Inc.
Stock option (right to buy)
2010-01-22+80,000→ 80,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2009-08-26+450,000→ 450,000 total
Award
Orexigen Therapeutics, Inc.
Stock Option (right to buy)
2009-08-26+150,000→ 150,000 total

Companies

Orexigen Therapeutics, Inc.
Chief Commercial Officer

Recent Filings

Address

C/O OREXIGEN THERAPEUTICS, INC. 3344 N. TORREY PINES COURT, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov